99 reports

  • Month & Year
  • ROAPAC: BODY COMPOSITION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • Obesity
  • Hologic, Inc.
  • InBody Co., Ltd.
  • Omron Corporation
  • Tanita Corporation
  • 4.2 ADOLESCENT AND CHILDHOOD BARIATRIC SURGERIES
  • 2.1 CATALYST
  • Medical Device
  • Obesity
  • World
  • Ethicon, Inc.
  • Medtronic, Inc.
  • A) Global diabetes and obesity market
  • Diabetes an d obesity
  • Obesity
  • World
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • GLOBAL OBESITY DRUGS MARKET 2016-2021 ($ BILLIONS)
  • Depression
  • Obesity
  • Allergan plc
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

Obesity: Disease Definition ##.

  • Obesity
  • Pathology
  • Europe
  • World
  • Forecast
  • Increasing focus of governments to reduce obesity in developed countries
  • MARKET DRIVERS
  • Gastroenterology
  • Obesity
  • World
  • Forecast
  • Medtronic, Inc.

Global Anti-Obesity Prescription Drugs Market Overview ##. ##.

  • Obesity
  • Pathology
  • Prescription Drug
  • World
  • Market Size

Introduction to Obesity ##. ## What is Obesity?

  • Obesity
  • Pathology
  • World
  • Forecast
  • Anti-obesity Drugs Imports
  • Anti-obesity Drugs Exports
  • Obesity
  • Pathology
  • China
  • Demand
  • Abbott Laboratories, Inc.

Global Obesity Management Market Analysis Scenario ##. ##.

  • Obesity
  • Pathology
  • North America
  • World
  • Forecast
  • Anti-obesity drugs Industry
  • Anti-Obesity Drug Industry Structure
  • Obesity
  • China
  • Abbott Laboratories, Inc.
  • Beijing Outsell Health Product Development Co., Ltd.
  • Shanghai Jahwa United Co., Ltd.
  • Market drivers
  • Obesity
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Worldwide, obesity has more than doubled since 1980.

  • Obesity
  • Pathology
  • World
  • Market Size

Obesity Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Obesity Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Obesity pipeline products, Obesity epidemiology, Obesity market v

  • Obesity
  • France
  • Germany
  • Italy
  • Market Size
  • EUROPEAN PARLIAMENT INITIATIVE TO TACKLE INCREASING OBESITY IN EUROPE
  • Untitled
  • Obesity
  • Apollo Endosurgery, Inc.
  • Hélioscopie SA
  • Obalon Therapeutics, Inc.
  • ReShape Medical, Inc.
  • OTC Obesity: Value Sales 2011-2016
  • Obesity and fast food consumption: Opportunity for WMW (2)
  • Obesity
  • World
  • Demand
  • Herbalife Ltd.
  • Kellogg Company
  • KEY MERGERS AND ACQUISITIONS
  • KEY PARTNERSHIPS
  • Obesity
  • Arena Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Novo Nordisk Group
  • VIVUS, Inc.
  • 3.5.4.3 Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D
  • MM, Sources Used, Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D
  • Obesity
  • France
  • Germany
  • Spain
  • Forecast

Complexities related to obesity treatment ##. ##. ##. ##.

  • Obesity
  • Pathology
  • World
  • Forecast
  • Market Size
  • EU, Total Prevalence of NAFLD and Obesity (%), Ages ≥20 Years, Both Sexes
  • 2.2 GLOBAL TRENDS
  • Obesity
  • Japan
  • United Kingdom
  • United States
  • Forecast

Obesity: Disease Definition ##.

  • Obesity
  • Europe
  • France
  • Germany
  • Forecast
  • 09.2 France
  • 10.2 Brazil
  • Obesity
  • Stretcher
  • Europe
  • World
  • Forecast
  • Anti-obesity drugs Industry
  • Anti-Obesity Drug Industry Structure
  • Obesity
  • China
  • Abbott Laboratories, Inc.
  • Beijing Outsell Health Product Development Co., Ltd.
  • Shanghai Jahwa United Co., Ltd.

Obesity Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Obesity Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Obesity pipeline products, Obesity epidemiology, Obesity market valu

  • Obesity
  • Europe
  • France
  • Germany
  • Market Size

Japan Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) Japan Obesity Epidemiology ##) Marketed Drugs for Obesity in Japan ##) Japan

  • Obesity
  • Pathology
  • Weight Loss
  • Japan
  • Market Size

Italy Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) Italy Obesity Epidemiology ##) Marketed Drugs for Obesity in Italy ##) Italy

  • Obesity
  • Pathology
  • Weight Loss
  • Italy
  • Market Size

Germany Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) Germany Obesity Epidemiology ##) Marketed Drugs for Obesity in Germany ##) German

  • Obesity
  • Pathology
  • Weight Loss
  • Germany
  • Market Size

France Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) France Obesity Epidemiology ##) Marketed Drugs for Obesity in France ##) France

  • Obesity
  • Pathology
  • Weight Loss
  • France
  • Market Size

UK Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) UK Obesity Epidemiology ##) Marketed Drugs for Obesity in UK ##) UK Obesity M

  • Obesity
  • Pathology
  • Weight Loss
  • United Kingdom
  • Market Size

US Obesity Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Obesity Treatments ##) Obesity Pipeline ##) US Obesity Epidemiology ##) Marketed Drugs for Obesity in US ##) US Obesity M

  • Obesity
  • Pathology
  • Weight Loss
  • Market Size